ArticleNature communications2022

Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8

Eishiro Mizukoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.